Taysha Gene Therapies, Inc.
TSHA
$5.95
-$0.04-0.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 455.41M | 276.58M | 319.77M | 297.34M | 312.76M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.27M | 1.46M | 974.00K | 806.00K | 495.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.75M | 4.21M | 3.91M | 1.80M | 3.01M |
| Total Current Assets | 461.43M | 282.25M | 324.65M | 299.95M | 316.26M |
|
|
|||||
| Total Current Assets | 461.43M | 282.25M | 324.65M | 299.95M | 316.26M |
| Net Property, Plant & Equipment | 8.73M | 15.61M | 16.18M | 14.27M | 14.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 270.00K | 2.50M | 2.50M | 2.34M | 2.34M |
| Total Assets | 470.43M | 300.35M | 343.32M | 316.55M | 333.33M |
|
|
|||||
| Total Accounts Payable | 9.16M | 4.56M | 6.28M | 5.44M | 7.71M |
| Total Accrued Expenses | 15.25M | 12.93M | 17.62M | 14.39M | 9.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.16M | 1.82M | 1.87M | 1.67M | 1.74M |
| Total Finance Division Other Current Liabilities | 398.00K | 784.00K | 796.00K | 7.14M | 6.89M |
| Total Other Current Liabilities | 398.00K | 784.00K | 796.00K | 7.14M | 6.89M |
| Total Current Liabilities | 25.98M | 20.10M | 26.55M | 28.63M | 25.35M |
|
|
|||||
| Total Current Liabilities | 25.98M | 20.10M | 26.55M | 28.63M | 25.35M |
| Long-Term Debt | 49.26M | 48.96M | 50.11M | 50.85M | 41.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.29M | 17.77M | 18.17M | 16.56M | 16.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.64M | 1.58M | 1.55M | 1.52M | 1.23M |
| Total Liabilities | 83.17M | 88.41M | 96.38M | 97.57M | 84.60M |
|
|
|||||
| Common Stock & APIC | 1.19B | 964.67M | 958.43M | 903.58M | 900.14M |
| Retained Earnings | -800.35M | -753.71M | -711.30M | -683.45M | -650.72M |
| Treasury Stock & Other | 769.00K | 985.00K | -192.00K | -1.14M | -699.00K |
| Total Common Equity | 387.27M | 211.94M | 246.94M | 218.99M | 248.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 387.27M | 211.94M | 246.94M | 218.99M | 248.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 387.27M | 211.94M | 246.94M | 218.99M | 248.73M |
|
|
|||||